Abstract-In order to examine a possible contribution of cyclic AMP to acetylcholine
It has been proposed that cyclic AMP is involved in neurotransmitter release from the nerve terminals of the central and peripheral nervous system.
(1-3). With respect to cholinergic neurons, however, the effect of cyclic AMP on acetylcholine (ACh) release is less extensively studied. Moreover, whether ACh release may be stimulated by cyclic AMP remains to be solved. Some reports supported the stimulatory effect of cyclic AMP on ACh release (4-6), others did not (7-9). In guinea pig ileum myenteric plexus too, there is evidence for (10) and against (11) the facilitatory action of cyclic AMP in ACh release, while an earlier report described that cyclic AMP depressed ACh release by electrical stimulation at low frequency (11); a recent one showed that 8-Br-cyclic AMP enhanced radiolabelled ACh release induced by electrical stimulation (10).
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Previously, we reported that the ACh release induced by nicotine but neither electrical field stimulation (EFS) nor high-K+ from guinea pig ileum myenteric plexus was dependent on endogenous prostaglandins and suggested that the cyclic AMP system could be involved in the mechanism of action of prostaglandin E2 (12-14). Based on our results that endogenous prostaglandins play a minor role in the ACh release induced by high-K+ or EFS but not nicotine, it was expected that the involvement of cyclic AMP itself in ACh release varied with the stimulus applied to the myenteric plexus. In view of this, the present experiment was designed to investigate the effects of adenylate cyclase inhibitors, phosphodies terase (PDE) inhibitors and dibutyryl cyclic AMP on ACh release induced by nicotine, high-K+ and EFS from the guinea pig ileum myenteric plexus.
Most of the spontaneous ACh release is thought to derive from the spontaneous activity of the neurones in the myenteric plexus (15-17). We showed that the spon taneous ACh release behaved as the nicotine induced one with respect to the involvement of prostaglandins (14) . Therefore, the effects of the above mentioned drugs on the spon taneous ACh release were also examined.
Materials and Methods

Preparation
of longitudinal muscle strips: Male guinea pigs, weighing 500 to 800 g, were killed by a blow on the head and bled. A length of small intestine was removed, about 10 cm of terminal ileum being dis carded.
Longitudinal muscle strips were prepared as previously described (17). Each of three strips were tied with cotton threads and mounted in an organ bath containing 3 ml Tyrode's solution of the following composition (mM): NaCl, 136.9; KCI, 2.7; CaC12, 1.8; MgC12, 1.05; NaHCO3, 0.4; and glucose, 5.6. Physostigmine salicylate (5 ,uM) and choline chloride (1 iiM) were added. The bath fluid was kept at 37'C and bubbled with 5% CO2 in 02.
ACh release induced by several stimuli: Before obtaining the samples for the esti mation of ACh release, the strips were equilibrated for 15 min during which the bath fluid was perfused at a rate of 1-2 ml/ min. Thereafter, the perfusion was stopped, and the samples were collected by replacing the bath fluid with 3 ml flesh Tyrode's solution. Collection periods were 1 or 2 min for the nicotine-induced one and 2 min for the high-K+-induced one. After two samples for the spontaneous ACh release were collected, the strips were stimulated by nicotine, by EFS or by high-K+. Each stimulus was performed twice with an interval of 19 min, 19 min and 23 min for nicotine, EFS and high-K+, in between, respectively. The first stimulation was carried out in the absence (Si) and the second stimulation in the presence (S2) of the drugs. For the EFS induced ACh release, stimulation was performed in trains of 20 sec, and bath fluid was collected after a further 10 sec of rest. EFS was carried out with a pair of Pt elec trodes, one at the top and one at the bottom of the strips; the parameters were: supra maximal voltage (100 V), 0.5 msec duration, 10 Hz, total 200 pulses. Such stimulation parameters produced the comparable output of ACh to the high-K+ (50 mM) or the nicotine (6.16 tiM) induced one. The high K+ (50 mM) Tyrode's solution was kept iso osmotic by appropriate changes in the Na+ concentration.
All the samples collected were kept on ice until assayed (within 3 hr). At the end of the experiment, the strips were blotted and weighed. The ACh release due to each stimulation was calculated by sub tracting the output collected during the immediately preceding 1 or 2 min resting period from the total output during the stimulation periods. All results in both the figures and the text of the present experi ments were given as relative ACh release defined with in the following way: ACh release during S2 was expressed as percent of that during S1. For the spontaneous ACh release, the spontaneous release immediately before S2 was expressed as percent of that immediately before S,.
Assay of ACh: The collected samples were gently shaken with one tenth volume of Amberlite XAD-2 for 15 min and filtrated to remove endogenous prostaglandins which were supposed to be included in the samples and the added nicotine (12, 18). The aliquouts were then assayed against ACh on the isolated longitudinal muscle strip which was obtained from the most distal region of guinea pig ileum. Physostigmine salicylate (50 nM) and morphine hydrochloride (10 itM) were added to the Tyrode's solution in the assay bath in order to increase the sensitivity of the longitudinal muscle strip to ACh and also to inhibit endogenous ACh release. The medium in the assay bath was kept at 37°C and bubbled with 5% CO2 in 02. To eliminate the possibility of inter ference with the assay by the drugs present in the collected samples, the responses to the bath fluids were compared with the standard ACh solution to which the drugs used were added to give the same final concentration.
Estimation of ACh was pre vented by alloxan because of its transient relaxative effect on longitudinal muscle. Therefore, when the samples containing alloxan were assayed, alloxan (0.4 mM) was always added to the Tyrode's solution in the assay bath in order to desensitize the muscle to the drug. The high-K+ Tyrode's solution had no effect on the assay of ACh because it was diluted 10-fold on addition to the fluid in the assay bath.
The acid was adjusted to pH 7.4 by adding 1 N HCI after being dissolved with diluted NaOH. Since the stock solution of alloxan was acidic, its solution was adjusted to pH 7.4 with 1 N NaOH.
The results were analysed using Student's t-test. *P<0 .05, compared with the control. The concentrations used were 1 mM, 1 mM, 4 mM, 4 mM and 1 mM for theophylline, IBMX, dibutyryl cyclic AMP (Dbcyclic AMP), alloxan and DTN B, respectively. R, : ACh release immediately before S1. R2: ACh release immediately before S2.
Discussion
It is suggested that prostaglandins act physiologically as modulator of cholinergic transmission in myenteric nerves (17, 19). However, on the basis of our previous reports that the nicotine-induced ACh release was suppressed by indomethacin, a prostaglandin synthetase inhibitor (13, 14), whereas the high-K+ (12) or EFS (13) induced one was not, the contribution of prostaglandins to ACh release seems to vary with the kind of stimuli applied to myenteric nerves. This idea may be supported by the observation that prostaglandin synthetase inhibitors sig nificantly reduced nicotine but not trans mural stimulation-induced contraction of guinea pig ileum (20). We also suggested that cyclic AMP system might be involved in the action of prostaglandin E2 in ACh release (13). Therefore, taking these findings and suggestion into account, our interest in the possibility that the contribution of cyclic AMP to ACh release varied with whether the ACh release was sensitive to endogenous prostaglandins led us to evaluate the ability of cyclic AMP to modulate the ACh release induced by various stimuli. Our present results, however, did not necessarily support the above possibility.
With respect to the nicotine-induced ACh release, the present results suggest that cyclic AMP is involved in the release since it was facilitated by theophylline and sup pressed by adenylate cyclase inhibitors. Theophylline, apart from its inhibitory action on PDE activity, is also reported to be able to release Ca" from intracellular sites at the concentration range used here (21). Hence , it would be incorrect to interpret the data as showing that the potentiating action of theophylline was exerted through increased cellular cyclic AMP level alone. Indeed failure of action of I BMX, another PDE inhibitor which has no evident Ca" releasing effect (22) but is more potent in inhibiting cyclic AMP-PDE (23), indicates that sig nificant increase of cyclic AMP level in the tissue may not result in potentiation of nicotine-induced ACh release. Thus the results could be explained by the conclusion that only a small amount of endogenous cyclic AMP may be necessary for maintaining the nicotine-induced ACh release. In contrast to the nicotine-induced ACh release, no drugs altered the EFS-induced ACh release. These results indicate that the EFS-induced ACh release is independent of cyclic AMP. This is in agreement with the results of Takagi and Takayanagi showing that dibutyryl cyclic AMP had no effect on the electrical stimulation-induced ACh release at high frequency from guinea pig ileum myenteric plexus (11). Although the measured ACh output originates not only from intrinsic myenteric nerves but also from extrinsic vagal fibers, the ACh output derived from the latter makes a neglegible con tribution to the measured ACh output (24, 25). Therefore, it seems unlikely that the different origin of ACh output is responsible for the lack of any effects by each of the drugs on the EFS-induced ACh release. Miyamoto and Breckenridge reported that stimulatory effect of dibutyryl cyclic AMP on neuromuscular transmission in the rat dia phragm was only observed in preparations exposed to high-K+ medium (26). In the present study, two PDE inhibitors and dibutyryl cyclic AMP increased and adenylate cyclase inhibitors decreased the high-K+ induced ACh release. These results clearly suggest that endogenous and exogenous cyclic AMP may regulate the ACh release.
In the case of the spontaneous ACh release, similar results, except those of dibutyryl cyclic AMP, to the nicotine induced ACh release were obtained. These results further support our previous sug gestion that most of the spontaneous ACh release may be due to the propagated activity through nicotinic receptors in myenteric nerves (14). However, dibutyryl cyclic AMP decreased the spontaneous ACh release without having any effects on the nicotine-induced one. We have no ex planation for this inconsistency at present. McAfee and Greengard concluded that an increase in cyclic AMP levels in the post ganglionic neurones makes the post synaptic membrane less sensitive to sub sequent excitatory input (27). Our data cannot be explained in this way since we found that the same dose of dibutyryl cyclic AMP which inhibited the spontaneous ACh release had no effect on the nicotine induced ACh release. However, if we assume that the spontaneous ACh release resulted from a far less excitated state of cholinergic nerves than that stimulated by nicotine, the decrease of the spontaneous ACh release by cyclic AMP might be explained as the results of its pharmacological action on the post synaptic membrane.
However, a detailed analysis of this possibility needs further investigations.
Takagi and Takayanagi showed that dibutyryl cyclic AMP and ATP depressed the ACh release and twitches in the guinea pig ileum induced by low fre quency (0.1 Hz) but not high frequency (50 Hz) (11).
